Restoration of FBXL4 expression via AAV9 delivery ameliorated cardiac hypertrophy and dysfunction in FBXL4-iCKO mice, while AAV9-mediated PFN1 knockdown or pharmacological inhibition partially reversed these phenotypes. This evidence concerns the gene PFN1 and cardiac hypertrophy.